An enthusiastic researcher with a strong background in pharmacology, molecular biology, and immunology, demonstrated through impactful research on vaccine development at the University of Auckland. Excelled in working on two prestigious projects on drug developments at Sree Chitra Tirunal Institute for Medical Science and Technology (an Institute of national importance under the Government of India). Skilled in scientific writing and mentoring, showcasing advanced data analysis capabilities and a commitment to pioneering healthcare solutions.
Project Handled
1. A technology enabling selective binding of active curcumin to human serum albumin from mixture of curcuminoids, yielding an intravenous formulation with anticancer/anti- inflammatory effects. (Processing, continuation-in-part of US20160129127A1).
2. A highly soluble intravenous formulation of dimethoxy curcumin-human serum albumin retaining proven biological activities and a process thereof (Application number: WO 202041020471/2020).
1. Korah MC, Harikrishnan VS, Deepa S, Arya A, Sabareeswaran A, Mohanan PV, Krishnan LK. Pharmacological safety of dimethoxy curcumin-human serum albumin conjugate for potential therapeutic purpose. Canadian Journal of Physiology and Pharmacology. 2023 Mar 3;101(6):304-15.
2. Korah MC, Hima SP, Anil A, Harikrishnan VS, Krishnan LK. Pharmacokinetics and Pharmacodynamics of Avian Egg-Yolk Derived Pure Anti-Snake Venom in Healthy and Disease Animal-Model. Journal of Pharmaceutical Sciences. 2022 Jun 1;111(6):1565-76.